[1]
Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(10): 2568-9.
[2]
Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009; 9(1): 186.
[3]
Ohshita K, Yamane K, Hanafusa M, et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care 2004; 27(2): 491-6.
[4]
Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 2002; 45(1): 42-8.
[5]
Maleki A, Rashidi N, Meybodi HA, et al. Metabolic syndrome and inflammatory biomarkers in adults: A population-based survey in Western region of Iran. ICRJ 2014; 8(4): 156.
[6]
Sefil F, Ulutas KT, Dokuyucu R, et al. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res 2014; 42(2): 581-8.
[7]
Karthikeyan V, Lip G. White blood cell count and hypertension. J Hum Hypertens 2006; 20(5): 310-2.
[8]
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16): 1685-95.
[9]
Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age-and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran lipid and glucose study. Clin Biochem 2014; 47(6): 432-8.
[10]
Karakasilioti I, Kamileri I, Chatzinikolaou G, et al. DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria. Cell Metab 2013; 18(3): 403-15.
[11]
Spoto B, Di Betta E, Mattace-Raso F, et al. Pro-and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis 2014; 24(10): 1137-43.
[12]
McLaughlin T, Deng A, Gonzales O, et al. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. Diabetologia 2008; 51(12): 2303-8.
[13]
Recasens M, Ricart W, Fernández-Real J. Obesity and inflammation. Revista de medicina de la Universidad de Navarra 2003; 48(2): 49-54.
[14]
Lubrano V, Venturi E, Balzan S, Baldi S, Natali A, Eds. Impact of risk factor for atherosclerosis on microvascular endothelial function: An in vitro study. Theoretical biology forum;. 2015.
[15]
Furuncuoğlu Y, Tulgar S, Dogan A, Cakar S, Tulgar Y, Cakiroglu B. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: A retrospective study. Eur Rev Med Pharmacol Sci 2016; 20(7): 1300-6.
[16]
Vargas R, Ryder E, Diez-Ewald M, et al. Increased C-reactive protein and decreased Interleukin-2 content in serum from obese individuals with or without insulin resistance: Associations with leukocyte count and insulin and adiponectin content. Diabetes Metab Syndr 2016; 10(1): S34-41.
[17]
Bastard J-P, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17(1): 4-12.
[18]
Pusuroglu H, Akgul O, Erturk M, et al. A comparative analysis of leukocyte and leukocyte subtype counts among isolated systolic hypertensive, systo-diastolic hypertensive, and non-hypertensive patients. Kardiol Pol 2014; 72(8): 748-54.
[19]
Schillaci G, Pirro M, Pucci G, et al. Prognostic value of elevated white blood cell count in hypertension. Am J Hypertens 2007; 20(4): 364-9.
[20]
Babio N, Ibarrola-Jurado N, Bulló M, et al. White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. PLoS One 2013; 8(3): e58354.
[21]
Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 2006; 19(4): 339-45.
[22]
Khovidhunkit W, , Memon RA,, Feingold KR, Grunfeld C,. Infection¶ and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000; 181(Supplement_3): : S462-72.
[23]
Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. Am J Med 2002; 112(4): 275-80.
[24]
Jiang H, Yan W-H, Li C-J, Wang A-P, Dou J-T, Mu Y-M. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health 2014; 11(5): 5497-509.
[25]
Hanley AJ, Retnakaran R, Qi Y, et al. Association of hematological parameters with insulin resistance and β-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 2009; 94(10): 3824-32.
[26]
Moradi S, Kerman SRJ, Rohani F, Salari F. Association between diabetes complications and leukocyte counts in Iranian patients. Int J Inflamm 2012; 5: 7.